Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Clin Pediatr. Jun 9, 2026; 15(2): 115247
Published online Jun 9, 2026. doi: 10.5409/wjcp.v15.i2.115247
Published online Jun 9, 2026. doi: 10.5409/wjcp.v15.i2.115247
Letter to the Editor: Bridging the immunization gap in pediatric autoimmune disorders - insights from inflammatory bowel disease and vaccine response patterns
Hany Akeel Al-Hussaniy, Department of Pharmacology, Al-Nisour University College, Baghdad 10001, Iraq
Author contributions: Al-Hussaniy HA contributed to wrote, corrected the article, analyzed the data, and writing the manuscript; the author had read and approved the final manuscript.
Conflict-of-interest statement: The author declares that he has no conflict of interest to disclose.
Corresponding author: Hany Akeel Al-Hussaniy, Professor, Department of Pharmacology, Al-Nisour University College, Baghdad Hayalkadsia, 602, 23, 17, Baghdad 10001, Iraq.
Received: October 14, 2025
Revised: November 20, 2025
Accepted: February 2, 2026
Published online: June 9, 2026
Processing time: 213 Days and 9.3 Hours
Revised: November 20, 2025
Accepted: February 2, 2026
Published online: June 9, 2026
Processing time: 213 Days and 9.3 Hours
Core Tip
Core Tip: Children with inflammatory bowel disease (IBD) may be more susceptible to other autoimmune diseases. They may also not get an adequate response to vaccines because of the medications they take to suppress their immunity. Recent studies have addressed this issue, especially in people with IBD, antibody levels, and vaccines, and their potential effectiveness, particularly against rubella and hepatitis B.